Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01134159
Other study ID # REWARDS TLX
Secondary ID
Status Completed
Phase N/A
First received May 27, 2010
Last updated June 1, 2011
Start date June 2010
Est. completion date September 2010

Study information

Verified date June 2011
Source Medstar Research Institute
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.


Recruitment information / eligibility

Status Completed
Enrollment 1200
Est. completion date September 2010
Est. primary completion date September 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients 18 years of age or older, both genders

- Underwent PCI with Taxus Liberte (alone) or Xience (alone)

Exclusion Criteria:

- Underwent PCI with a non-Taxus Liberte or Xience V DES during the same procedure

- Received both Taxus-Liberte and Xience-V during the same index procedure

- Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel or prasugrel).

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Locations

Country Name City State
United States Medical University of South Carolina Charleston South Carolina
United States Midwest Cardiovascular Research Foundation Davenport Iowa
United States Genesys Regional Medical Center Grand Blanc Michigan
United States Grand Strand Regional Medical Center Myrtle Beach South Carolina
United States Oklahoma Foundation for Cardiovascular Research Oklahoma City Oklahoma
United States Maine Medical Center Portland Maine
United States Heart Clinics Northwest Spokane Washington
United States Washington Adventist Hospital Takoma Park Maryland
United States Washington Hospital Center Washington District of Columbia
United States Iowa Heart Center West Des Moines Iowa

Sponsors (2)

Lead Sponsor Collaborator
Medstar Research Institute Boston Scientific Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Major adverse cardiac events, A composite of all-cause death, Q-wave myocardial infarction, and target vessel revascularization 1 year No
Secondary Stent thrombosis 1 year No
Secondary Target vessel revascularization 1 year No
Secondary Cardiac death 1 year No
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A